Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4Q2V2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.476 |
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.427 |
CLV_PCSK_FUR_1 | 75 | 79 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.427 |
DOC_MAPK_gen_1 | 4 | 11 | PF00069 | 0.591 |
DOC_MAPK_gen_1 | 49 | 59 | PF00069 | 0.308 |
DOC_MAPK_MEF2A_6 | 52 | 61 | PF00069 | 0.308 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.473 |
LIG_14-3-3_CanoR_1 | 118 | 123 | PF00244 | 0.712 |
LIG_14-3-3_CanoR_1 | 4 | 13 | PF00244 | 0.526 |
LIG_BRCT_BRCA1_1 | 22 | 26 | PF00533 | 0.385 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.707 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.455 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.550 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.659 |
LIG_SH2_GRB2like | 13 | 16 | PF00017 | 0.385 |
LIG_SH2_SRC | 111 | 114 | PF00017 | 0.636 |
LIG_SH2_SRC | 13 | 16 | PF00017 | 0.342 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.670 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.331 |
LIG_TYR_ITIM | 56 | 61 | PF00017 | 0.331 |
MOD_CK2_1 | 70 | 76 | PF00069 | 0.641 |
MOD_GlcNHglycan | 107 | 111 | PF01048 | 0.519 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.456 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.695 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.699 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.633 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.520 |
MOD_PK_1 | 118 | 124 | PF00069 | 0.676 |
MOD_PKA_1 | 118 | 124 | PF00069 | 0.642 |
MOD_PKA_1 | 77 | 83 | PF00069 | 0.629 |
MOD_PKA_2 | 118 | 124 | PF00069 | 0.747 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.676 |
MOD_PKB_1 | 75 | 83 | PF00069 | 0.684 |
MOD_Plk_1 | 106 | 112 | PF00069 | 0.619 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.458 |
TRG_DiLeu_LyEn_5 | 101 | 106 | PF01217 | 0.599 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.329 |
TRG_ER_diArg_1 | 3 | 6 | PF00400 | 0.577 |
TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.600 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEA3 | Leptomonas seymouri | 59% | 100% |
A0A1X0PAJ5 | Trypanosomatidae | 37% | 100% |
A0A3Q8IFM2 | Leishmania donovani | 93% | 100% |
A0A422P096 | Trypanosoma rangeli | 37% | 88% |
A4HAV9 | Leishmania braziliensis | 77% | 100% |
A4IA19 | Leishmania infantum | 94% | 100% |
E9B534 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |